6 Amendments of Seán KELLY related to 2011/0402(CNS)
Amendment 168 #
Proposal for a decision
Recital 8
Recital 8
(8) In order to maintain and increase the Union's industrial leadership there is an urgent need to stimulate private sector research and development and innovation investment, promote research and innovation with a business driven agenda and accelerate the development of new technologies which will underpin future businesses and economic growth. Part II "Industrial leadership" should support investments in excellent research and innovation in key enabling technologies and other industrial technologies, facilitate access to risk finance for innovative companies and projects, and provide Union wide support for innovation in small and medium-sized enterprises, primarily by lowering the entry threshold for small and medium-sized enterprises.
Amendment 352 #
Proposal for a decision
Annex 1 – point 2 – paragraph 6 – point f a (new)
Annex 1 – point 2 – paragraph 6 – point f a (new)
(fa) Radio Astronomy research between Europe and Africa, as called for in European Parliament's adopted Written Declaration 45/2011 and the 2011 African Union Summit, leveraging Africa's own investments and geographical advantages for a mutually beneficial partnership with Europe.
Amendment 374 #
Proposal for a decision
Annex 1 – point 4 – paragraph 7
Annex 1 – point 4 – paragraph 7
Further public-public partnerships and public-private partnerships may be launched under Horizon 2020 where they meet the defined criteria. This may include partnerships on Information and Communication Technologies in the areas of Photonics and Robotics, on sustainable process industries, on bio-based industries and, on telemedicine and home treatment appliances, on security technologies for maritime border surveillance.
Amendment 597 #
Proposal for a decision
Annex 1 – section 3 – point 1 – paragraph 4
Annex 1 – section 3 – point 1 – paragraph 4
All of these activities will be undertaken in such a way as to provide support throughout the research and innovation cycle, strengthening the competitiveness of the European based industries and SMEs and development of new market opportunities.
Amendment 642 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.11 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.11 – paragraph 1
There is a need to support the development of scientific tools, methods and statistics for rapid, accurate and predictive assessment of the safety, efficacy and quality of health technologies including new drugs, biologics, advanced therapies and medical devices. This is particularly relevant for new developments in domains including those concerning vaccines, cell/tissue and gene therapies, organs and transplantation, specialist manufacturing, bio banks, new medical devices, diagnostic/treatment procedures, genetic testing, interoperability, telemedicine and e-health, including privacy aspects. Similarly, support for improved risk assessment methodologies, testing approaches and strategies relating to environment and health are required. There is also a need to support the development of relevant methods for assisting the assessment of ethical aspects of the above domains.
Amendment 664 #
Proposal for a decision
Annex 1 – section 3 – point 2 – introductory part
Annex 1 – section 3 – point 2 – introductory part
2. Food safety, healthy food and food security, sustainable agriculture, marine and maritimeountain research and the bio- economy